Four Decades for Justice
Benjamin J.
Bauer
Practice Area Attorney, Litigation
Benjamin J. Bauer focuses on antitrust litigation and merger clearance matters.
Mr. Bauer is a seasoned antitrust lawyer and has experience representing multinational clients across all phases of the merger review process in the United States and globally—from preliminary risk assessment through litigation in federal court. In addition, Mr. Bauer has represented corporate and individual clients in a wide range of antitrust conduct investigations and related proceedings, including cartel defense and follow-on civil litigation.
Before joining Cravath, Mr. Bauer worked at global law firms in Washington, D.C. and New York. Mr. Bauer started his legal career at the Federal Trade Commission’s (FTC) Bureau of Competition, first as an Honors Paralegal, and later as a Legal Intern in the Mergers I Division.
Mr. Bauer currently serves as a Vice Chair of the Compliance and Ethics Committee of the American Bar Association’s Antitrust Law Section.
Mr. Bauer was born in Schenectady, New York. He received a B.A. magna cum laude from Union College in 2008, where he was elected to Phi Beta Kappa, and a J.D. from Georgetown University Law Center in 2013. After graduating from law school, Mr. Bauer served as a law clerk to Judge Sally D. Adkins of the Supreme Court of Maryland.
Mr. Bauer is a seasoned antitrust lawyer and has experience representing multinational clients across all phases of the merger review process in the United States and globally—from preliminary risk assessment through litigation in federal court. In addition, Mr. Bauer has represented corporate and individual clients in a wide range of antitrust conduct investigations and related proceedings, including cartel defense and follow-on civil litigation.
Before joining Cravath, Mr. Bauer worked at global law firms in Washington, D.C. and New York. Mr. Bauer started his legal career at the Federal Trade Commission’s (FTC) Bureau of Competition, first as an Honors Paralegal, and later as a Legal Intern in the Mergers I Division.
Mr. Bauer currently serves as a Vice Chair of the Compliance and Ethics Committee of the American Bar Association’s Antitrust Law Section.
Mr. Bauer was born in Schenectady, New York. He received a B.A. magna cum laude from Union College in 2008, where he was elected to Phi Beta Kappa, and a J.D. from Georgetown University Law Center in 2013. After graduating from law school, Mr. Bauer served as a law clerk to Judge Sally D. Adkins of the Supreme Court of Maryland.
Education
-
J.D., 2013, Georgetown University Law Center
-
B.A., 2008, Union CollegePhi Beta Kappa, magna cum laude
Clerkships
- Hon. Sally D. Adkins, U.S. Supreme Court of Maryland
Admitted In
- New York
- District of Columbia
Deals & Cases
September 11, 2023
Amgen Successfully Defends Against FTC Challenge, Securing Clearance for its $27.8 Billion Acquisition of Horizon Therapeutics
Cravath represented Amgen, one of the world’s largest biopharmaceutical companies, in successfully defending against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that The Wall Street Journal described as “a rare instance” of the FTC “throwing in the towel on litigation.”
Benjamin J. Bauer focuses on antitrust litigation and merger clearance matters.
Mr. Bauer is a seasoned antitrust lawyer and has experience representing multinational clients across all phases of the merger review process in the United States and globally—from preliminary risk assessment through litigation in federal court. In addition, Mr. Bauer has represented corporate and individual clients in a wide range of antitrust conduct investigations and related proceedings, including cartel defense and follow-on civil litigation.
Before joining Cravath, Mr. Bauer worked at global law firms in Washington, D.C. and New York. Mr. Bauer started his legal career at the Federal Trade Commission’s (FTC) Bureau of Competition, first as an Honors Paralegal, and later as a Legal Intern in the Mergers I Division.
Mr. Bauer currently serves as a Vice Chair of the Compliance and Ethics Committee of the American Bar Association’s Antitrust Law Section.
Mr. Bauer was born in Schenectady, New York. He received a B.A. magna cum laude from Union College in 2008, where he was elected to Phi Beta Kappa, and a J.D. from Georgetown University Law Center in 2013. After graduating from law school, Mr. Bauer served as a law clerk to Judge Sally D. Adkins of the Supreme Court of Maryland.
Mr. Bauer is a seasoned antitrust lawyer and has experience representing multinational clients across all phases of the merger review process in the United States and globally—from preliminary risk assessment through litigation in federal court. In addition, Mr. Bauer has represented corporate and individual clients in a wide range of antitrust conduct investigations and related proceedings, including cartel defense and follow-on civil litigation.
Before joining Cravath, Mr. Bauer worked at global law firms in Washington, D.C. and New York. Mr. Bauer started his legal career at the Federal Trade Commission’s (FTC) Bureau of Competition, first as an Honors Paralegal, and later as a Legal Intern in the Mergers I Division.
Mr. Bauer currently serves as a Vice Chair of the Compliance and Ethics Committee of the American Bar Association’s Antitrust Law Section.
Mr. Bauer was born in Schenectady, New York. He received a B.A. magna cum laude from Union College in 2008, where he was elected to Phi Beta Kappa, and a J.D. from Georgetown University Law Center in 2013. After graduating from law school, Mr. Bauer served as a law clerk to Judge Sally D. Adkins of the Supreme Court of Maryland.
Education
-
J.D., 2013, Georgetown University Law Center
-
B.A., 2008, Union CollegePhi Beta Kappa, magna cum laude
Clerkships
- Hon. Sally D. Adkins, U.S. Supreme Court of Maryland
Admitted In
- New York
- District of Columbia
Deals & Cases
September 11, 2023
Amgen Successfully Defends Against FTC Challenge, Securing Clearance for its $27.8 Billion Acquisition of Horizon Therapeutics
Cravath represented Amgen, one of the world’s largest biopharmaceutical companies, in successfully defending against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that The Wall Street Journal described as “a rare instance” of the FTC “throwing in the towel on litigation.”
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. © 2023 Cravath, Swaine & Moore LLP.